Entities / Company
Vaxart.
American biotechnology company based in San Francisco
- Reports this week
- 0
- Active events
- 0
- Connections
- 24
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
OTC Markets Group welcomed Vaxart to the OTCQX market on July 8, 2025.Speculative1 report
-
Vaxart appointed Steven Lo as Chief Executive Officer and Michael J. Finney as Chairman of the Board on September 3, 2025.Some support5 reports
-
Vaxart was classified in the Zacks Medical - Drugs industry as of August 14, 2025.Some support1 report
-
David Whitney is a concerned stockholder of Vaxart.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Vaxart this week
News at the entities that move Vaxart most-
MarketBeat Mentioned togetherApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Vaxart
Connections
The 4 strongest of 24, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sean Tucker Structural
Sean Tucker serves as the Founder and Chief Scientific Officer of Vaxart.
-
Steven Lo Structural
Steven Lo serves as the Chief Executive Officer of Vaxart.
-
Institutional Shareholder Services Structural
ISS provides proxy voting recommendations that influence Vaxart's corporate governance decisions.
-
MarketBeat Mentioned together
MarketBeat provides average rating data and stock coverage for Vaxart.
History
Events by the month they beganAugust 2026
1 eventJuly 2026
1 eventJune 2026
4 events- OTC Markets Group welcomed Vaxart to the OTCQX market on July 8, 2025.
- Vaxart appointed Steven Lo as Chief Executive Officer and Michael J. Finney as Chairman of the Board on September 3, 2025.
- Vaxart was classified in the Zacks Medical - Drugs industry as of August 14, 2025.
- David Whitney is a concerned stockholder of Vaxart.